Healio

iFR, FFR confer similar safety at 5 years in real-world population

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Strategies guided by instantaneous wave-free ratio and ...
Nasdaq

iFR and FFR are equally safe to diagnose and treat heart disease according to largest-ever analysis of new real-world, long-term data

Safety of Philips’ iFR in the guidance of percutaneous coronary intervention (PCI) for heart disease demonstrated in late-breaking science at TCT 2023 highlighting patient-level outcomes analysis of ...
Medscape

ORBITA: FFR/iFR Predict Ischemia but Not Symptoms After PCI

PARIS — New findings from the controversial ORBITA trial provide a lift for percutaneous coronary intervention (PCI) in stable angina but also mixed results for the predictive power of fractional flow ...
Nasdaq

Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack ...

3-Year data from the largest global trial to date using Class I, Level A iFR in heart attack patients shows treating additional stenoses in the same procedure showed no significant difference in major ...